GlassScriptPhysician profile
John C Axley
NPI 1528421708
$6,365.99
in general payments reported to CMS, 2019-2025
26 companies · $1,253 in 2025
The $1,253 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $2,636 · 2023: $1,232 · 2024: $1,245 · 2025: $1,253.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,730.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,729.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Silk Road Medical, INC. | $1,674.12 | 2022-2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Endologix LLC | $1,333.06 | 2023-2025 | Alto Abdominal Stent Graft System, Torus Stent Graft System, Endocross Device |
| W. L. Gore & Associates, INC. | $964.26 | 2022-2025 | Gore Viabahn Vbx Balloon Expandable Endo, Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Tag Thoracic Branch Endoprosthesis |
| Medtronic, INC. | $725.79 | 2022-2025 | Hawkone, Abre, Venaseal |
| Penumbra, INC. | $348.92 | 2022-2025 | Penumbra System, Indigo System |
| Philips North America LLC | $231.66 | 2022-2023 | |
| Reflow Medical INC | $182.95 | 2023-2025 | |
| Bolton Medical INC | $162.33 | 2022-2023 | Relay Thoracic Stent-Graft With Plus Delivery System |
| Shockwave Medical, INC | $140.12 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Mozarc Medical US LLC | $107.60 | 2023 | Chameleon, Palindrome |
| Angiodynamics, INC. | $67.35 | 2023 | Auryon Laser System 100-120 Vac |
| Veryan Medical Incorporated | $63.31 | 2022-2023 | Biomimics 3d Vascular Stent System |
| Mimedx Group, INC. | $41.11 | 2024 | |
| Bard Peripheral Vascular, INC. | $39.78 | 2024-2025 | Rotarexs 6 F X 135 Cm, Denali Vena Cava Filter |
| Kerecis Limited | $39.31 | 2023-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $36.39 | 2024 | |
| Boston Scientific Corporation | $32.09 | 2023-2025 | Eluvia, Varithena Administration Pack |
| Conmed Corporation | $31.67 | 2025 | Airseal, Conmed Specimen Retrieval |
| Artivion, INC. | $31.14 | 2025 | Vascular, Photofix Decellularized Bovine Pericardium |
| Kci USA, INC. | $23.65 | 2023 | V.A.C. Veraflo |
| Solventum Corporation | $23.51 | 2024 | Activ.A.C. |
| Pfizer INC. | $20.20 | 2022 | |
| Ethicon US, LLC | $19.64 | 2025 | Evarrest, Surgicel Nu-Knit, Vistaseal |
| Cook Medical LLC | $15.94 | 2024 | Zenith |
| Lemaitre Vascular, INC. | $7.13 | 2023 | Artegraft Vascular Graft |
| Cardiovascular Systems INC. | $2.96 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Axley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.